Tradestie Institutional Equity Comparison Engine

CCOR vs DRSK โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CCOR Overall Edge

CCOR Captures Institutional Edge (2โ€“0 Pillars ยท 2โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Core Alternative Capital (CCOR) driven by superior Momentum & Technical, Options & Structure. Fundamentally, CCOR trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus DRSK at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, CCOR sits in UNCLASSIFIED (50th %ile IV; Dealer Gamma Walls on Pro) against DRSK sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
CCOR N/M vs DRSK N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner CCOR
1Y +6.6% vs -7.3% ยท 52W Pos 79% vs 3%
Options & Structure Winner CCOR
UNCLASSIFIED (50th %ile IV) vs UNCLASSIFIED (N/A IV)
CCOR NYSE Arca
Core Alternative Capital
Institutional Equity
$27.66
+0.33% 1D
Market Cap N/A
1M Return +5.99%
1Y Return +6.6%
Forward P/E N/M
Unified AI Score
45.4 / 100 HOLD
Tech 28.0 Fund 33.0 Flow 50.0 Mom 21.2
DRSK Cboe BZX
Aptus Defined Risk ETF
Institutional Equity
$26.96
+0.07% 1D
Market Cap N/A
1M Return -1.06%
1Y Return -7.35%
Forward P/E N/M
Unified AI Score
43.7 / 100 HOLD
Tech 31.0 Fund 51.0 Flow 50.0 Mom 70.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CCOR +6.6% DRSK -7.35% Spread: +13.31 pp (CCOR Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CCOR TTM Op. Margin: N/A DRSK TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CCOR vs DRSK. Trailing 12-month operating profitability (CCOR N/A vs DRSK N/A) and valuation multiples (CCOR N/M vs DRSK N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CCOR (2) vs DRSK (1)
Institutional Metric CCOR DRSK Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 79% ($25โ€“$28) 3% ($27โ€“$30) Stronger Trend CCOR
Beta / 30D Volatility Risk Regime -0.16ฮฒ ยท 19% Vol 0.32ฮฒ ยท 5% Vol Lower Realized Risk DRSK
Unified Institutional Score Composite Signal 45.4 / 100 (HOLD) 43.7 / 100 (HOLD) Higher Composite CCOR

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CCOR vs DRSK Buy Guide
CCOR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 50th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live CCOR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
DRSK UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live DRSK Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CCOR nor DRSK registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.